Celldex (TCE2) Ownership - Who Owns Celldex?
Celldex (TCE2) Ownership Overview
- 0.30% Insiders
- 30.85% Mutual Funds
- 1.54% Other Institutional Investors
- 14.68% ETFs
- 52.63% Public Companies and Individual Investors
The ownership structure of Celldex (DE:TCE2) stock is a mix of institutional, retail, and individual investors. Approximately 47.07% of the company’s stock is owned by Institutional Investors, 0.30% is owned by Insiders, and 52.63% is owned by Public Companies and Individual Investors.
The ownership structure of Celldex (DE:TCE2) stock is a mix of institutional, retail, and individual investors. Approximately 47.07% of the company’s stock is owned by Institutional Investors, 0.30% is owned by Insiders, and 52.63% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 07, 2025 | Freddy A. Jimenez | $121,189 | |
| Nov 16, 2025 | Richard M. Wright | $1,183,152 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Woodline Partners Lp | €13,583,449 | |
| Dec 31, 2025 | Fisher Asset Management Llc | €25,453,211 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 7,002,530 | Institution | 8.92% | 206,756,701 |
| Vanguard | 4,151,685 | Institution | 5.29% | 122,582,651 |
| Vanguard Specialized Funds | 3,783,994 | Institution | 4.82% | 111,726,207 |
| Vanguard Index Funds | 3,385,288 | Institution | 4.31% | 99,954,013 |
| Ishares | 3,071,897 | Institution | 3.91% | 90,700,831 |
| Spdr | 1,946,727 | Institution | 2.48% | 57,479,061 |
| Fidelity Concord Street Trust | 1,844,189 | Institution | 2.35% | 54,451,524 |
| Vanguard Explorer Fund | 1,447,608 | Institution | 1.84% | 42,742,074 |
| T. Rowe Price New Horizons Fund, Inc. | 1,254,603 | Institution | 1.60% | 37,043,408 |
| Felix Baker | 1,182,611 | Institution | 1.51% | 34,917,772 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Specialized Funds | 3,783,994 | Institution | 4.82% | 111,726,207 |
| Vanguard Index Funds | 3,385,288 | Institution | 4.31% | 99,954,013 |
| Fidelity Concord Street Trust | 1,844,189 | Institution | 2.35% | 54,451,524 |
| Vanguard Explorer Fund | 1,447,608 | Institution | 1.84% | 42,742,074 |
| T. Rowe Price New Horizons Fund, Inc. | 1,254,603 | Institution | 1.60% | 37,043,408 |
| Mutual Fund Series Trust | 1,079,784 | Institution | 1.38% | 31,881,702 |
| T. Rowe Price Integrated Equity Funds, Inc. | 1,076,931 | Institution | 1.37% | 31,797,465 |
| Fidelity Salem Street Trust | 946,686 | Institution | 1.21% | 27,951,851 |
| Federated Hermes Equity Funds | 854,942 | Institution | 1.09% | 25,243,017 |
| American Century Mutual Funds, Inc. | 793,241 | Institution | 1.01% | 23,421,234 |
FAQ
Who Owns Celldex (DE:TCE2)?
According to the latest TipRanks data, approximately 47.07% of the company's stock is held by institutional investors, 0.30% is held by insiders, and 52.63% is held by public companies and individual investors.
What percentage of Celldex (DE:TCE2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 47.07% of Celldex (DE:TCE2) stock is held by institutional investors: 30.85% by mutual funds, 14.68% by ETFs and 1.54% by other institutional investors.
What percentage of Celldex (DE:TCE2) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.63% of Celldex (DE:TCE2) stock is held by public companies and individual investors.
Who owns the most shares of Celldex (DE:TCE2)?
BlackRock, Inc. owns the most shares of Celldex (DE:TCE2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
